Clinical Trial Update: Effects of Cannabis on Cognition and Endocannabinoid Levels in Bipolar Disorder Patients and Healthy Volunteers [EARLY_Phase 1]

View source ↗

Summary

This update reports that the EARLY Phase 1 clinical trial evaluating the effects of cannabis on cognition and endocannabinoid levels in bipolar disorder patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Cannabis (Cannabis)

Snippet

Sponsor: University of California, San Diego | Conditions: Bipolar Disorder | EARLY_Phase 1 | Status: TERMINATED